BioNxt Solutions Inc.
BNXT
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.70M | -5.02M | -4.41M | -4.32M | -4.09M |
| Total Depreciation and Amortization | 12.90K | 8.00K | 21.10K | 34.00K | 45.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.69M | 2.04M | 1.63M | 1.69M | 1.63M |
| Change in Net Operating Assets | -231.10K | -747.30K | -956.20K | 188.60K | 17.50K |
| Cash from Operations | -3.23M | -3.72M | -3.71M | -2.41M | -2.39M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 90.00K | 97.30K | 94.60K | 59.30K | 99.10K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.30K | -36.30K | -36.30K | -- | -- |
| Cash from Investing | 53.70K | 61.00K | 58.30K | 59.30K | 99.10K |
| Total Debt Issued | 1.25M | 4.64M | 6.75M | 5.50M | 5.50M |
| Total Debt Repaid | -1.71M | -3.42M | -4.45M | -4.45M | -2.74M |
| Issuance of Common Stock | 2.94M | 2.60M | 2.06M | 704.40K | 1.22M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.59M | 1.30M | 1.13M | 1.24M | -510.10K |
| Cash from Financing | 2.95M | 3.67M | 3.93M | 2.12M | 2.46M |
| Foreign Exchange rate Adjustments | 500.00 | 1.20K | 1.10K | 1.50K | 1.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -225.20K | 12.70K | 275.20K | -230.40K | 170.30K |